Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Journal of Palliative Medicine
|
March 6, 2004
Refractory status epilepticus
Mary Golf, Judith A Paice, Edna Feulner, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
March 4, 2025
Recent and anticipated novel drug approvals (1Q 2025 through 4Q 2025)
Matthew H Rim, Brittany L Karas, Farah Barada, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
December 31, 2025
Recent and anticipated novel drug approvals (4Q 2025 through 3Q 2026)
Brittany L Karas, Mary Golf, Elizabeth Shepard, et al.
JAMA Oncology
|
May 30, 2024
Obstacles to Biosimilar Acceptance and Uptake in Oncology: A Review
Daniel K Mroczek, Katherina Hauner, George J Greene, et al.
Cancer
|
March 14, 2007
Monitoring plasma voriconazole levels may be necessary to avoid subtherapeutic levels in hematopoietic stem cell transplant recipients
Steve Trifilio, Gennethel Pennick, Judy Pi, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Journal of Palliative Medicine
|
March 6, 2004
Refractory status epilepticus
Mary Golf, Judith A Paice, Edna Feulner, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
March 4, 2025
Recent and anticipated novel drug approvals (1Q 2025 through 4Q 2025)
Matthew H Rim, Brittany L Karas, Farah Barada, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
December 31, 2025
Recent and anticipated novel drug approvals (4Q 2025 through 3Q 2026)
Brittany L Karas, Mary Golf, Elizabeth Shepard, et al.
JAMA Oncology
|
May 30, 2024
Obstacles to Biosimilar Acceptance and Uptake in Oncology: A Review
Daniel K Mroczek, Katherina Hauner, George J Greene, et al.
Cancer
|
March 14, 2007
Monitoring plasma voriconazole levels may be necessary to avoid subtherapeutic levels in hematopoietic stem cell transplant recipients
Steve Trifilio, Gennethel Pennick, Judy Pi, et al.
Page
of 1